BiodesixBDSX

13F holders, Q3 2025 (September 30)
1holders −40
0new positions
20sold out
$7.55avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Biodesix Inc. (BDSX) in their 13F filings, down 40 from Q2 2025. 0 opened new positions and 20 sold out. The largest holder was Birchview Capital, LP ($2.2M).

Company
Biodesix Inc.
CUSIP
09075X108
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 42Q1 2024Q2 2024: 46Q2 2024Q3 2024: 52Q3 2024Q4 2024: 59Q4 2024Q1 2025: 60Q1 2025Q2 2025: 41Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits20$2.1M

All 13F filers, Q2 2025 → Q3 2025: 13,010,754 shares sold, net −13,010,754 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Birchview Capital, LP 1.63% Reduce -95.0% 286,804 $2.2M

"% of holder's portfolio" is BDSX's weight in each manager's 13F, not the share of Biodesix Inc. the manager owns.